[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

These 3 Charts Look Like Thoroughbreds: Get Derby-Ready With My Racetrack-to-SPY Roadmap

While many people started to learn about the stock market and investing for the first time during the pandemic, as a semi-retired investor, I did things a little differently. With the stock market already under my belt, so to speak, the pandemic is when my interest in horse racing first started to expand beyond the casual.

Why? Because for a while, it was about the only sport that didn’t miss a beat. Races from around the US continued on, while the major sports leagues tried to figure out their plan. 

Fundamentals

See More
  • Market Capitalization, $K 883,027,776
  • Shares Outstanding, K 944,819
  • Annual Sales, $ 65,179 M
  • Annual Income, $ 20,640 M
  • EBIT $ 26,302 M
  • EBITDA $ 28,299 M
  • 60-Month Beta 0.51
  • Price/Sales 12.34
  • Price/Cash Flow 34.77
  • Price/Book 31.14

Options Overview Details

View History
  • Implied Volatility 35.69% (+0.48%)
  • Historical Volatility 41.38%
  • IV Percentile 37%
  • IV Rank 42.37%
  • IV High 47.67% on 07/30/25
  • IV Low 26.88% on 09/04/25
  • Expected Move (DTE 7) 36.13 (3.87%)
  • Put/Call Vol Ratio 0.40
  • Today's Volume 2,052
  • Volume Avg (30-Day) 39,635
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 358,564
  • Open Int (30-Day) 322,460
  • Expected Range 898.47 to 970.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $8.43
  • Number of Estimates 6
  • High Estimate $8.92
  • Low Estimate $7.83
  • Prior Year $6.31
  • Growth Rate Est. (year over year) +33.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
850.51 +14.69%
on 04/29/26
978.46 -0.31%
on 05/01/26
+20.89 (+2.19%)
since 04/01/26
3-Month
850.51 +14.69%
on 04/29/26
1,114.00 -12.44%
on 02/04/26
-61.74 (-5.95%)
since 01/30/26
52-Week
623.78 +56.37%
on 08/08/25
1,133.95 -13.98%
on 01/08/26
+181.32 (+22.83%)
since 05/01/25

Most Recent Stories

More News
These 3 Charts Look Like Thoroughbreds: Get Derby-Ready With My Racetrack-to-SPY Roadmap

Our resident ROAR columnist explains how he got into horse racing, and how stock market fans can find a favorite for this weekend.

QQQ : 672.92 (+0.78%)
MA : 504.45 (+0.30%)
BRK.B : 475.95 (+0.50%)
XOM : 154.66 (+0.21%)
LLY : 978.48 (+4.70%)
EEM : 64.35 (+0.56%)
SPY : 722.43 (+0.52%)
LLY Q1 Deep Dive: Obesity Franchise Expansion and Pipeline Investment Drive Outperformance

LLY Q1 Deep Dive: Obesity Franchise Expansion and Pipeline Investment Drive Outperformance

LLY : 978.48 (+4.70%)
GLP-1 Sales Continue to Lift Eli Lilly. Does That Make LLY Stock a Buy?

Eli Lilly stock rallies as GLP-1 sales drive a 56% year-on-year increase in Q1 revenue. Jim Cramer recommends buying LLY shares as the weight-loss addressable market is truly huge.

LLY : 978.48 (+4.70%)
S&P 500 and Nasdaq 100 Rally to Record Highs on Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +1.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.98%. June E-mini...

TER : 345.55 (+0.61%)
AMAT : 393.84 (-0.16%)
GOOGL : 380.98 (-0.99%)
ADI : 395.28 (-1.74%)
TXN : 277.48 (-1.28%)
$IUXX : 27,608.16 (+0.57%)
ASML : 1,431.13 (-0.55%)
ZNM26 : 110-175 (-0.04%)
MSFT : 414.55 (+1.66%)
ESM26 : 7,276.75 (+0.46%)
QCOM : 172.69 (-3.84%)
ORLY : 98.99 (-0.41%)
Stocks Rally as Nasdaq 100 Posts a New Record High on Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.39%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. June E-mini S&P futures (ESM26...

TER : 345.55 (+0.61%)
GOOGL : 380.98 (-0.99%)
F : 11.90 (-1.49%)
$IUXX : 27,608.16 (+0.57%)
ZNM26 : 110-175 (-0.04%)
MSFT : 414.55 (+1.66%)
ESM26 : 7,276.75 (+0.46%)
QCOM : 172.69 (-3.84%)
ORLY : 98.99 (-0.41%)
W : 62.81 (-1.75%)
LLY : 978.48 (+4.70%)
$DOWI : 49,787.95 (+0.27%)
Stocks See Support from Lower Crude Prices, While Mega-Cap Tech Earnings are Mixed

The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM26...

TER : 345.55 (+0.61%)
GOOGL : 380.98 (-0.99%)
F : 11.90 (-1.49%)
$IUXX : 27,608.16 (+0.57%)
ZNM26 : 110-175 (-0.04%)
MSFT : 414.55 (+1.66%)
ESM26 : 7,276.75 (+0.46%)
ORLY : 98.99 (-0.41%)
QCOM : 172.69 (-3.84%)
W : 62.81 (-1.75%)
LLY : 978.48 (+4.70%)
$DOWI : 49,787.95 (+0.27%)
Eli Lilly (NYSE:LLY) Delivers Strong Q1 CY2026 Numbers, Stock Soars

Eli Lilly (NYSE:LLY) Delivers Strong Q1 CY2026 Numbers, Stock Soars

LLY : 978.48 (+4.70%)
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

INDIANAPOLIS , April 30, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first quarter of 2026 and provided updated 2026 financial guidance.

LLY : 978.48 (+4.70%)
Stocks Rise Before the Open as Investors Weigh Big Tech Earnings, Iran War News

June S&P 500 E-Mini futures (ESM26) are up +0.15%, and June Nasdaq 100 E-Mini futures (NQM26) are up +0.22% this morning as investors digest earnings reports from big U.S. tech companies and the latest...

TER : 345.55 (+0.61%)
GOOGL : 380.98 (-0.99%)
META : 612.55 (+0.10%)
AAPL : 283.88 (+4.62%)
SNDK : 1,120.00 (+2.14%)
BNP.FP : 89.230 (-1.41%)
NXPI : 286.01 (-2.58%)
MRK : 113.16 (+3.65%)
GLE.FP : 68.440 (-3.59%)
ESM26 : 7,276.75 (+0.46%)
MSFT : 414.55 (+1.66%)
UMG.A.DX : 17.828 (-7.29%)
Eli Lilly's Obesity Franchise Hype: Is the Prescription Data Already Telling a Different Story?

Barchart Research What to Expect from LLY Earnings LLY Generated April 29, 2026 Current Price $851.21 EPS Estimate $$7.06 Consensus Rating Strong Buy Average Move 8.12% Eli Lilly's Obesity Franchise Hype:...

LLY : 978.48 (+4.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 1,003.17
2nd Resistance Point 974.33
1st Resistance Point 954.47
Last Price 977.63
1st Support Level 905.77
2nd Support Level 876.93
3rd Support Level 857.07

See More

52-Week High 1,133.95
Last Price 977.63
Fibonacci 61.8% 939.07
Fibonacci 50% 878.86
Fibonacci 38.2% 818.66
52-Week Low 623.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.